NYSE · Household & Personal Products

Kenvue Inc. (KVUE) Stock

$19.48 +1.04% NYSE: KVUE Consumer Defensive

Kenvue Inc. functions as a global leader in the consumer health sector.

Valuation

MetricValue
Price$19.48
Market Cap$37.40B
P/E Ratio23.14
P/B Ratio3.14
P/S Ratio2.16
EPS (TTM)$0.76
52-Week High$22.87
52-Week Low$14.02
Dividend Yield4.83%

Financials & Margins

MetricValue
ROE13.66%
ROA5.43%
ROCE25.12%
Gross Margin17.88%
Operating Margin17.88%
Net Margin10.61%
Debt/Equity0.82
Current Ratio0.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.1B$14.9B$15.4B$15.5B$15.1B
Operating Profit$2.9B$2.7B$2.5B$1.8B$2.7B
Net Profit$2.1B$2.1B$1.7B$1.0B$1.5B
EPS$1.10$1.08$0.87$0.54$0.76
Op Margin19.4%17.9%16.3%11.9%17.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$27.9B$27.3B$27.9B$25.6B$27.1B
Total Liabilities$7.5B$7.3B$16.6B$15.9B$16.3B
Cash$740.0M$1.2B$1.4B$1.1B$1.1B
Borrowings$129.0M$9.0B$8.4B$8.7B$8.5B

Latest News

Analyst Report: Johnson & Johnson Morningstar Research · Jul 15, 2026 4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential 24/7 Wall St. · Jul 14, 2026 Sector Update: Healthcare Stocks Advance Late Afternoon MT Newswires · Jul 13, 2026 Sector Update: Healthcare Stocks Higher Monday Afternoon MT Newswires · Jul 13, 2026 KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits Stocktwits · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$334.0M$2.5B$3.2B$1.8B$2.2B
Investing Cash Flow$-466.0M$-765.0M$-957.0M$-859.0M$-911.0M
Financing Cash Flow$7.0M$-1.6B$-460.0M$-172.0M$-106.0M
Net Cash Flow$122.0M$491.0M$151.0M$-312.0M$-8.0M
Free Cash Flow$39.0M$2.1B$2.7B$1.3B$1.7B

Valuation & Return Ratios

MetricValue
PEG Ratio54.17
EV / EBITDA12.36
FCF Yield5.53%
Quick Ratio0.70
Interest Coverage7.13
Return 1Y-7.56%
Return 3Y-8.55%
Return 5Y—

Ownership

Insiders Held0.05%
Institutions Held94.83%
Institutions Float Held94.88%
Institutional HolderSharesReport Date
Blackrock Inc.145,297,2922026-03-31
FMR, LLC135,093,0942026-03-31
Vanguard Capital Management LLC124,424,0372026-03-31
State Street Corporation119,571,2462026-03-31
Vanguard Portfolio Management LLC92,464,3882026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADMArcher-Daniels-Midland Company $82.37 -0.99% 31.04 $39.70B 2.96%
CHDChurch & Dwight Co., Inc. $100.43 +1.75% 32.39 $23.80B 1.22%
ELThe Estée Lauder Companies Inc. $81.65 +1.69% 28.47 $29.53B 1.54%
HSYThe Hershey Company $178.71 +2.53% 33.66 $36.25B 3.12%
JBSJbs N.V. $13.70 +0.66% 1.60 $30.39B 6.27%

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Kenvue Inc. is led by CEO Kirk L. Perry, employs 22,000 people, headquartered in Summit, US, publicly traded since 2023.

Kenvue Inc. (KVUE) stock trades at $19.48 with a market capitalization of $37.40B. The stock is valued at a price-to-earnings (P/E) ratio of 23.14, price-to-book of 3.14, price-to-sales of 2.16. Over the past 52 weeks the stock has ranged between $14.02 and $22.87, and currently trades 14.8% below its 52-week high. It pays a dividend yielding 4.83%.

On profitability, Kenvue Inc. generates a return on equity (ROE) of 13.66%, above the typical market average, return on capital employed of 25.12%, an operating margin of 17.88%, a net profit margin of 10.61%.

In its most recent fiscal year, Kenvue Inc. reported annual revenue of $15.1B, net profit of $1.5B, revenue has compounded at 0.9% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 0.82, a current ratio of 0.96, total assets of $27.1B, $1.1B in cash and equivalents.

KVUE has an average daily trading volume of 20,040,000 shares, a beta of 0.50 (less volatile than the overall market).

Official website: www.kenvue.com

Related Consumer Defensive Stocks

WMT Discount Stores $111.85 -0.20% COST Discount Stores $947.82 -0.14% KO Beverages - Non-Alcoholic $87.05 +0.23% PG Household & Personal Products $145.77 -0.82% PM Philip Morris International Inc. $198.44 -0.86% PEP Beverages - Non-Alcoholic $139.02 +0.42% MO Altria Group, Inc. $74.92 +0.13% MNST Beverages - Non-Alcoholic $97.23 -0.52% MDLZ Food Confectioners $64.99 +4.02% CL Household & Personal Products $93.49 +0.82% TGT Discount Stores $145.97 +1.23% DEO Beverages - Wineries & Distilleries $89.16 +0.29%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides